CN1939279A - 用于缓解慢性阻塞性肺病症状的沙丁胺醇和异丙托铵吸入溶液、系统、试剂盒和方法 - Google Patents

用于缓解慢性阻塞性肺病症状的沙丁胺醇和异丙托铵吸入溶液、系统、试剂盒和方法 Download PDF

Info

Publication number
CN1939279A
CN1939279A CNA2006101077523A CN200610107752A CN1939279A CN 1939279 A CN1939279 A CN 1939279A CN A2006101077523 A CNA2006101077523 A CN A2006101077523A CN 200610107752 A CN200610107752 A CN 200610107752A CN 1939279 A CN1939279 A CN 1939279A
Authority
CN
China
Prior art keywords
solution
albuterol
suction
aerosol apparatus
containers
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA2006101077523A
Other languages
English (en)
Chinese (zh)
Inventor
伊姆蒂亚兹·肖迪
帕索·班纳吉
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mylan Specialty LP
Original Assignee
Dey LP
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP2002158304A external-priority patent/JP2003221335A/ja
Application filed by Dey LP filed Critical Dey LP
Publication of CN1939279A publication Critical patent/CN1939279A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Dispersion Chemistry (AREA)
  • Otolaryngology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
CNA2006101077523A 2001-10-26 2002-10-18 用于缓解慢性阻塞性肺病症状的沙丁胺醇和异丙托铵吸入溶液、系统、试剂盒和方法 Pending CN1939279A (zh)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US34607801P 2001-10-26 2001-10-26
US60/346,078 2001-10-26
US10/034,657 2001-12-27
US3465701A 2001-12-28 2001-12-28
AU32974/02A AU3297402A (en) 2001-10-26 2002-04-05 An albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease
AU32974/02 2002-04-05
JP2002158304A JP2003221335A (ja) 2001-10-26 2002-04-23 慢性閉塞性肺疾患の症状を緩和するためのアルブテロールおよびイプラトロピウム吸入溶液、システム、キットおよび方法
JP158304/2002 2002-04-23
PCT/US2002/033353 WO2003037159A2 (fr) 2001-10-26 2002-10-18 Solution d'inhalation a base d'albuterol et d'ipratropium, et systeme, kit et methode permettant de soulager les symptomes de la bronchopneumopathie chronique obstructive

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CNA028262263A Division CN1607940A (zh) 2001-10-26 2002-10-18 用于缓解慢性阻塞性肺病症状的沙丁胺醇和异丙托铵吸入溶液、系统、试剂盒和方法

Publications (1)

Publication Number Publication Date
CN1939279A true CN1939279A (zh) 2007-04-04

Family

ID=27422968

Family Applications (2)

Application Number Title Priority Date Filing Date
CNA2006101077523A Pending CN1939279A (zh) 2001-10-26 2002-10-18 用于缓解慢性阻塞性肺病症状的沙丁胺醇和异丙托铵吸入溶液、系统、试剂盒和方法
CNA028262263A Pending CN1607940A (zh) 2001-10-26 2002-10-18 用于缓解慢性阻塞性肺病症状的沙丁胺醇和异丙托铵吸入溶液、系统、试剂盒和方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
CNA028262263A Pending CN1607940A (zh) 2001-10-26 2002-10-18 用于缓解慢性阻塞性肺病症状的沙丁胺醇和异丙托铵吸入溶液、系统、试剂盒和方法

Country Status (8)

Country Link
EP (1) EP1446045A4 (fr)
JP (1) JP2006505486A (fr)
CN (2) CN1939279A (fr)
AU (1) AU3297402A (fr)
CA (1) CA2464735C (fr)
MX (1) MXPA04003927A (fr)
NZ (1) NZ552548A (fr)
WO (1) WO2003037159A2 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106344544A (zh) * 2016-08-25 2017-01-25 杭州百诚医药科技股份有限公司 一种用于治疗支气管哮喘的雾化吸入制剂
CN115209872A (zh) * 2020-03-19 2022-10-18 广州谷森制药有限公司 含有酒石酸左旋沙丁胺醇的可吸入制剂

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1915985A1 (fr) * 2003-03-20 2008-04-30 Boehringer Ingelheim Pharmaceuticals Inc. Formulation pour une dose mesurée utilisant des hydro-fluoro-alcanes en tant que propulseurs
GB0501956D0 (en) * 2005-01-31 2005-03-09 Arrow Internat Nebulizer formulation
JP2009537570A (ja) * 2006-05-18 2009-10-29 ティカ レーケメデル アーベー アルブテロールの吸入可能溶液を有する単位用量製剤
WO2007134965A1 (fr) * 2006-05-19 2007-11-29 Boehringer Ingelheim International Gmbh Formulation d'aérosol contenant du bromure d'ipratropium et du sulfate de salbutamol
EP2026785A1 (fr) * 2006-05-19 2009-02-25 Boehringer Ingelheim International GmbH Formulation d'aérosol sans gaz propulseur destinée à être inhalée, contenant du bromure d'ipratropium et du sulfate de salbutamol
EP2077132A1 (fr) 2008-01-02 2009-07-08 Boehringer Ingelheim Pharma GmbH & Co. KG Dispositif distributeur, dispositif de stockage et procédé pour la distribution d'une formulation
EP2414560B1 (fr) 2009-03-31 2013-10-23 Boehringer Ingelheim International GmbH Procédé de revêtement d'une surface d'un composant
JP5763053B2 (ja) 2009-05-18 2015-08-12 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング アダプタ、吸入器具及びアトマイザ
JP5658268B2 (ja) 2009-11-25 2015-01-21 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ネブライザ
CN102686260B (zh) 2009-11-25 2014-10-01 贝林格尔.英格海姆国际有限公司 喷雾器
US10016568B2 (en) 2009-11-25 2018-07-10 Boehringer Ingelheim International Gmbh Nebulizer
JP5874724B2 (ja) 2010-06-24 2016-03-02 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ネブライザ
WO2012106382A1 (fr) * 2011-01-31 2012-08-09 Genoa Pharmaceuticals, Inc. Composés analogues de pyridone et de pirfénidone en aérosol, et leurs utilisations
WO2012130757A1 (fr) 2011-04-01 2012-10-04 Boehringer Ingelheim International Gmbh Appareil médical pourvu d'un récipient
US9827384B2 (en) 2011-05-23 2017-11-28 Boehringer Ingelheim International Gmbh Nebulizer
WO2013152894A1 (fr) 2012-04-13 2013-10-17 Boehringer Ingelheim International Gmbh Pulvérisateur comprenant des moyens de détrompage
JP6643231B2 (ja) 2013-08-09 2020-02-12 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ネブライザ
PL2835146T3 (pl) 2013-08-09 2021-04-06 Boehringer Ingelheim International Gmbh Nebulizator
DK2897589T3 (en) * 2013-11-22 2018-03-12 Teva Branded Pharmaceutical Prod R & D Inc Inhalable drug
PL2897588T3 (pl) * 2013-11-22 2019-12-31 Teva Branded Pharmaceutical Products R&D, Inc. Lek wziewny
US10716907B2 (en) 2014-05-07 2020-07-21 Boehringer Ingelheim International Gmbh Nebulizer
ES2954961T3 (es) 2014-05-07 2023-11-27 Boehringer Ingelheim Int Unidad, nebulizador y método
PL3139984T3 (pl) 2014-05-07 2021-11-08 Boehringer Ingelheim International Gmbh Nebulizator
CN110898042B (zh) * 2019-12-12 2020-10-16 深圳大佛药业股份有限公司 一种吸入用硫酸沙丁胺醇溶液剂及其制备方法
CN111053761B (zh) * 2020-01-16 2022-05-03 杭州旦承医药科技有限公司 一种吸入用双膦酸类药物及其制备方法及其在慢性阻塞性肺疾病的用途
CN113018280A (zh) * 2021-03-01 2021-06-25 石家庄四药有限公司 一种异丙托溴铵吸入用溶液制剂及其制备方法
CN115645381B (zh) * 2022-10-20 2023-05-30 深圳大佛药业股份有限公司 一种盐酸左沙丁胺醇雾化吸入溶液缓释剂及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0673240B1 (fr) * 1992-12-09 1999-03-24 Boehringer Ingelheim Pharmaceuticals Inc. Formulations de solutions medicinales aerosol stabilisees
DE19653969A1 (de) * 1996-12-20 1998-06-25 Boehringer Ingelheim Kg Neue wässrige Arzneimittelzubereitung zur Erzeugung treibgasfreier Aerosole
US6247617B1 (en) * 1999-12-13 2001-06-19 Richard Allen Clyde Single use container for dispensing separately housed sterile compositions

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106344544A (zh) * 2016-08-25 2017-01-25 杭州百诚医药科技股份有限公司 一种用于治疗支气管哮喘的雾化吸入制剂
CN115209872A (zh) * 2020-03-19 2022-10-18 广州谷森制药有限公司 含有酒石酸左旋沙丁胺醇的可吸入制剂

Also Published As

Publication number Publication date
CA2464735A1 (fr) 2003-05-08
JP2006505486A (ja) 2006-02-16
WO2003037159A2 (fr) 2003-05-08
AU3297402A (en) 2003-10-30
MXPA04003927A (es) 2005-03-31
EP1446045A4 (fr) 2010-07-21
CA2464735C (fr) 2011-03-22
CN1607940A (zh) 2005-04-20
EP1446045A2 (fr) 2004-08-18
WO2003037159A3 (fr) 2003-10-16
NZ552548A (en) 2009-03-31

Similar Documents

Publication Publication Date Title
CN1939279A (zh) 用于缓解慢性阻塞性肺病症状的沙丁胺醇和异丙托铵吸入溶液、系统、试剂盒和方法
CN1720036A (zh) 用于缓解儿科哮喘症状的沙丁胺醇吸入溶液、系统、试剂盒和方法
US6632842B2 (en) Albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease
CN1155410C (zh) 治疗尼古丁成瘾的含有尼古丁受体拮抗剂和抗抑郁药或抗焦虑药的组合物
RU2384333C2 (ru) Применение флибансерина для лечения предменструальных и иных сексуальных расстройств у женщин
CN1241569C (zh) 用于治疗鼻炎/结膜炎的非镇静抗组胺药物与影响白三烯活性物质的新药物并用
US6436938B1 (en) Combination treatment for depression
US20060264511A1 (en) Method for the treatment of drug-induced sexual dysfunction
CN1791430A (zh) 非典型抗精神病药物和gaba调节剂、抗惊厥药物或苯并二氮杂䓬类的治疗性组合
JPH08208471A (ja) 薬物反応の増強作用
US10143676B2 (en) Doxepin trans isomers and isomeric mixtures and methods of using the same to treat sleep disorders
EP3646870A1 (fr) Procédés et compositions pour le traitement de troubles améliorés par l'activation du récepteur muscarinique
RU2268725C2 (ru) Комбинация лекарственных препаратов, включающая миртазапин, для лечения депрессии и связанных расстройств
US20070249582A1 (en) Method of Treating Substance Abuse with Quetiapine
JPH0796034A (ja) カルシトニンを含む鼻内投薬のための噴霧装置
US20030203930A1 (en) Albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease
BE1004485A3 (fr) Compositions pharmaceutiques.
AU2006202585B2 (en) An albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease
US20030140920A1 (en) Albuterol inhalation soultion, system, kit and method for relieving symptoms of pediatric asthma
CN1925841A (zh) 用于口腔的药物制剂
US8084461B2 (en) Albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease
AU2006202584B2 (en) An albuterol inhalation solution, system, kit and method for relieving symptoms of pediatric asthma
CN1498613A (zh) 5－ht3受体拮抗剂鼻粘膜喷雾给药组合物及其用途
CA2464660C (fr) Solution d'inhalation a base d'albuterol, et systeme, kit et methode permettant de soulager les symptomes de l'asthme pediatrique
US20140228402A1 (en) Combinations Comprising a S1P receptor modulator

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication

Open date: 20070404